Leakage of cardiac troponin I in aortic valve stenosis

Journal of Internal Medicine

Volumn 258, Issue 3, 2005, Pages 231-237

  Kupari, Markku ^a   Eriksson, S ^b   Turto, H ^a   Lommi, J ^a   Pettersson, K ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Aortic valve stenosis; Heart failure; Troponins

Indexed keywords

TROPONIN I;

ADULT; AGED; AORTA ROOT; AORTA VALVE STENOSIS; ARTICLE; BLOOD SAMPLING; CELL DAMAGE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY SINUS; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CELL; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AGED; ANALYSIS OF VARIANCE; AORTIC VALVE STENOSIS; BIOLOGICAL MARKERS; CELL DEATH; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HUMANS; MALE; MIDDLE AGED; MYOCYTES, CARDIAC; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; TROPONIN I; VENTRICULAR DYSFUNCTION, LEFT;

EID: 24144489695     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2005.01529.x     Document Type: Article

References (28)

1. Lund O, Emmertsen K, Dorup I, Jensen FT, Flo C. Regression of left ventricular hypertrophy during 10 years after valve replacement for aortic stenosis is related to the preoperative risk profile. Eur Heart J 2003; 24: 1437-46.
2. Gaudino M, Alessandrini F, Glieca F et al. Survival after aortic valve replacement for aortic stenosis: does left ventricular mass regression have a clinical correlate? Eur Heart J 2005; 26: 51-7.
3. Hein S, Arnon E, Kostin S et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 2003; 107: 984-91.
4. Hamm CW, Braunwald E. A classification of unstable angina revisited. Circulation 2000; 102: 118-22.
5. Missov E, Calzolari C, Pau B. Circulating troponin I in severe congestive heart failure. Circulation 1997; 96: 2953-8.
6. Del Carlo CH, O'Connor CM. Cardiac troponins in congestive heart failure. Am Heart J 1999; 138: 646-53.
7. Horwich TB, Patel J, MacLellan R, Fonarow GC. Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation 2003; 108: 833-8.
8. Perna ER, Macin SM, Cimbaro Canella JP et al. Ongoing myocardial injury in stable severe heart failure. Value of cardiac troponin T monitoring for high risk patients identification. Circulation 2004; 110: 2376-82.
9. Sato Y, Kita Y, Takatsu Y, Kimura T. Biochemical markers of myocyte injury in heart failure. Heart 2004; 90: 1110-3.
10. Lindroos M, Kupari M, Heikkila J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol 1993; 21: 1220-5.
11. Kupari M, Koskinen P, Virolainen J. Correlates of left ventricular mass in a population sample aged 36 to 37 years. Circulation 1994; 89: 1050-9.
12. Devereux RB, Alonso DR, Lutas EM et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450-8.
13. Devereux RB, Lutas EM, Casale PN et al. Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol 1984; 4: 1222-30.
14. The Task Force on Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis of heart failure. Eur Heart J 1995; 16: 741-51.
15. Kupari M, Turto H, Lommi J. Diagnosing heart failure in aortic valve stenosis. J Intern Med 2004; 256: 381-8.
16. Bland JM, Altman DG. Statistics notes: measurement error. Br Med J 1996; 313: 744.
17. Nunes JPL, Garcia JMM, Farinha RMB et al. Cardiac troponin I in aortic valve disease. Int J Cardiol 2003; 89: 281-5.
18. Kemp M, Donovan J, Higham H, Hooper J. Biochemical markers of myocardial injury. Br J Anesth 2004; 93: 63-73.
19. Roongsritong C, Warraich I, Bradley C. Common causes of troponin elevations in the absence of acute myocardial infarction. Incidence and clinical significance. Chest 2004; 125: 1877-84.
20. Giannitis E, Muller-Bardorff M, Volkhard K et al. Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation 2000; 102: 211-7.
21. Bonnefoy E, Gordon P, Kirkorian G, Fatemi M, Chevalier P, Touboul P. Serum cardiac troponin I and ST-segment elevation in patients with acute pericarditis. Eur Heart J 2000; 21: 832-6.
22. Smith SC, Ladenson JH, Mason JW, Jaffe AS. Elevations of cardiac troponin I associated with myocarditis, experimental and clinical correlates. Circulation 1997; 95: 163-8.
23. verElst KM, Spapen HD, Nam Nguyen L, Garbar C, Huyghens LP, Gorus FK. Cardiac troponins I and T are biological markers of left ventricular dysfunction in septic shock. Clin Chem 2000; 46: 650-7.
24. Sato Y, Yamada T, Taniguchi R et al. Persistently increased serum concentrations of cardiac troponin T in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes. Circulation 2001; 103: 369-74.
25. Sato Y, Taniguchi T, Nagai K et al. Measurements of cardiac troponin T in patients with hypertrophic cardiomyopathy. Heart 2003; 89: 659-60.
26. Cardinale D, Sandri MT, Martinoni A et al. Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy. J Am Coll Cardiol 2000; 36: 517-22.
27. Setsuta K, Seino Y, Ogawa T, Arao M, Miyatake Y, Takano T. Use of cytosolic and myofibrillar markers in the detection of ongoing myocardial damage in patients with chronic heart failure. Am J Med 2002; 113: 717-22.
28. Krayenbuehl H, Hess OM, Monrad ES, Schneider J, Mall G, Turina M. Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement. Circulation 1989; 79: 744-55.